Another crucial aspect in the diagnosis of neoplasms with GLI1 alterations is that while amplification is reliably detected by FISH, rearrangement is typically identified through genomic sequencing (NGS, RNAseq), which is not universally accessible. The gene discussed is GLI1; the disease is neoplasm.